Activation of microtubule-associated protein kinase (Erk) and p70 S6 kinase by D2 dopamine receptors

Journal of Neurochemistry

Volumn 70, Issue 5, 1998, Pages 2139-2146

  Welsh, Gavin I ^a,c   Hall, David A ^a,d   Warnes, Andrew ^a   Strange, Philip G ^a,b   Proud, Christopher G ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c INSTITUT PASTEUR   (France)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

D2 receptor; Dopamine; Microtubule associated protein kinase; p70 S6 kinase

Indexed keywords

DOPAMINE 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN);

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; CYTOSOL; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ANIMALIA;

EID: 0031969728     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70052139.x     Document Type: Article

References (59)

1. 2-adrenergic receptors expressed in fibroblasts. J. Biol. Chem. 268, 22235-22238.
2. Alessi D. R., Gomez N., Moorhead G., Lewis T., Keyse S. M., and Cohen P. (1995) Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr. Biol. 5, 283-295.
3. Arcaro A. and Wymann M. P. (1993) Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296, 297-301.
4. Bogoyevitch M. A., Clerk A., and Sugden P. H. (1995) Activation of the mitogen-activated protein kinase cascade by pertussis-toxin-sensitive and pertussis-toxin-insensitive pathways in cultured ventricular cardiomyocytes. Biochem. J. 309, 437-443.
5. Brunn G. J., Williams J., Sabers C., Weiderrecht G., Lawrence J. C., and Abraham R. T. (1996) Direct inhibition of the signalling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15, 5256-5267.
6. Bunzow J. R., Van Tol H. H. M., Grandy D. K., Albert P., Salon J., Christie M., Machida C. A., Neve K. A., and Civelli O. (1988) Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 336, 783-787.
7. 2 dopamine receptor. J. Neurochem. 60, 372-375.
8. Cheatham B., Vlahos C. J., Cheatham L., Wang L., Blenis J., and Kahn C. R. (1994) Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis and glucose transporter translocation. Mol. Cell. Biol. 14, 4902-4911.
9. Chung J., Kuo C. J., Crabtree G. R., and Blenis J. (1992) Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69, 1227-1236.
10. Chung J., Grammer T. C., Lemon K. P., Kazlauskas A., and Blenis J. (1994) PDGF- and insulin-dependent pp70s6k activation mediated by phosphatidylinositol 3-OH kinase. Nature 370, 71-75.
11. Cobb M. H. and Goldsmith E. J. (1995) How MAP kinases are regulated. J. Biol. Chem. 270, 14843-14846.
12. Crews C. M. and Erikson R. L. (1993) Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74, 215-217.
13. Cross M. J., Stewart A., Hodgkin M. N., Kerr D. J., and Wakelam M. J. O. (1995) Wortmannin and its structural analog demethoxyviridin inhibit stimulated phospholipase A(2) activity in Swiss 3T3 cells - wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J. Biol. Chem. 270, 25352-25355.
14. Crowley S., Paterson H., and Marshall C. J. (1994) Activation of MAP kinase kinase is necessary and sufficient for PC 12 differentiation and transformation of NIH 3T3 cells. Cell 77, 841-852.
15. Dahl J., Freund R., Blenis J., and Benjamin T. L. (1996) Studies of partially transforming polyomavirus mutants establish a role for phosphatidylinositol 3-kinase in activation of pp70 S6 kinase. Mol. Cell. Biol. 16, 2728-2735.
16. Diggle T. A., Moule S. K., Avison M. B., Flynn A., Foulstone E. J., Proud C. G., and Demon R. M. (1996) Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor 4E binding protein (4E-BP1) in response to insulin in rat epididymal fat cells. Biochem. J. 316, 447-453.
17. Dikic I., Tokiwa G., Lev S., Courtneidge S. A., and Schlessinger J. (1996) A role for Pyk2 and Src in linking G-protein-receptors with MAP kinase activation. Nature 383, 547-550.
18. Faure M., Voyno-Yasenetskaya T. A., and Bourne H. R. (1994) cAMP and β,γ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J. Biol. Chem. 269, 7851-7854.
19. 2long dopamine receptors expressed in recombinant cells. Br. J. Pharmacol. 118, 1544-1550.
20. Garnovskaya M. N., van Biesen T., Hawes B., Casamar Ramos S., Lefkowitz R. J., and Raymond J. R. (1996) Ras-dependent activation of fibroblast mitogen-activated protein kinase by 5HT1A receptor via G-protein β-γ subunit initiated pathway. Biochemistry 35, 13716-13722.
21. Hall D. A. and Strange P. G. (1997) Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors. Br. J. Pharmacol. 121, 731-736.
22. q-mediated mitogen-activated protein kinase activation. J. Biol. Chem. 270, 17148-17153.
23. 2B subtypes in a heterologous cell line. Mol. Endocrinol. 6, 920-926.
24. Huwiler A., Stabel S., Fabbro D., and Pfeilschifter J. (1995) Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. J. Biochem. 305, 777-784.
25. Khosravi-Far R., Solski P. A., Clark G. J., Kinch M. S., and Der C. J. (1995) Activation of Rac1, RhoA and mitogen-activated kinases is required for ras transformation. Mol. Cell. Biol. 15, 6443-6453.
26. Kido Y., Okabayashi Y., Okutani T., Sugimoto Y., Sakaguchi K., and Kasuga M. (1995) EGF-induced activation of the 70 kDa S6 kinase in CHO cells expressing human EGF receptors. Biochem. Biophys. Res. Commun. 209, 131-138.
27. ras. Proc. Natl. Acad. Sci. USA 91, 12706-12710.
28. Kolch W. G., Heidecker G., Lloyd P., and Rapp U. R. (1991) Raf-1 kinase is required for growth of induced NIH 3T3 cells. Nature 349, 426-428.
29. Kuo C. J., Chung J., Fiorentino D. F., Flanagan W. M., Blenis J., and Crabtree G. R. (1992) Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358, 70-73.
30. Lajiness M. E., Chio C. L., and Huff R. M. (1993) D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylations. J. Pharmacol. Exp. Ther. 267, 1573-581.
31. s6k function is essential for G1 progression. Nature 363, 170-172.
32. Marshall C. J. (1995) Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal regulated kinase activation. Cell 80, 179-185.
33. Misra-Press A., Rim C. S., Yao H., Roberson M. S., and Stork P. J. S. (1995) A novel mitogen-activated protein kinase phosphatase - structure, expression and regulation. J. Biol. Chem. 270, 14587-14596.
34. S6k. Mol. Cell. Biol. 17, 5648-5655.
35. Moule S. K., Edgell N. J., Welsh G. I., Diggle T. A., Foulstone E. J., Heesom K. J., Proud C. G., and Denton R. M. (1995) Multiple signalling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat pads. Biochem. J. 311, 595-601.
36. Moule S. K., Welsh G. I., Foulstone E. J., Heesom K., Edgell N., Proud C. G., and Denton R. M. (1997) Regulation of protein kinase B and glycogen synthase kinase 3 by insulin and β-adrenergic agonists in rat epididymal fat cells. Activation of protein kinase B by wortmannin-sensitive and -insensitive mechanisms. J. Biol. Chem. 272, 7713-7719.
37. Neve K. A. and Neve R. L. (1997) The Dopamine Receptors. Humana Press, Totowa, New Jersey.
38. Petritsch C., Woscholski R., Edelmann H. M. L., Parker P. J., and Ballou L. M. (1995) Selective inhibition of p70 S6 kinase activation by phosphatidylinositol 3-kinase inhibitors. Eur. J. Biochem. 230, 431-438.
39. Plevin R., Scott P. H., Robinson C. J. M., and Gould G. W. (1996) Efficacy of agonist-stimulated MEK activation determines the susceptibility of mitogen activated protein (MAP) kinase to inhibition in rat aortic smooth muscle cells. Biochem. J. 318, 657-663.
40. Proud C. G. (1996) p70 S6 kinase: an enigma with variations. Trends Biochem. Sci. 21, 181-185.
41. Reinhard C., Fernandez A., Lamb N. J. C., and Thomas G. (1994) Nuclear localization of p85s6k: functional requirement tor entry into S-phase. EMBO J. 13, 1557-1565.
42. Rodriguez-Viciana P., Warne P. H., Dhand R., Vanhaesebroeck B., Gout I., Fry M. J., Waterfield M. D., and Downward J. (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527-532.
43. Rodriguez-Viciana P., Warne P. H., Vanhaesebroeck B., Waterfield M. D., and Downward J. (1996) Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 15, 2442-2451.
44. Rubio I., Rodriguez Viciana P., Downward J., and Wetzker R. (1997) Interaction of Ras with phosphomositide 3-kinase γ. Biochem. J. 326, 891-895.
45. Rvdzewska G., Jurkowska G., and Gabryelewicz A. (1996) Phospholipase-D mediated transphosphatidylation as a possible new pathway of ethanol-metabolism in isolated rat pancreatic acini. J. Physiol. Pharmacol. 47, 385-395.
46. Stephens L., Hawkins P. T., Eguinoa A., and Cooke F. (1994) A heterotrimeric GTPase-regulated isoform of PI3K and the regulation of its potential effectors. Philos. Trans. R. Soc. Lond. [Biol.] 351, 211-216.
47. Sugiyama H., Papst P., Fujita M., Gelfand E. W., and Terada N. (1997) Overexpression of wild type p70 S6 kinase interferes with cytokinesis. Oncogene 15, 443-452.
48. Sun H., Charles C. H., Lau L. F., and Tonks N. K. (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487-493.
49. Susa M., Vulevic D., Lane H. A., and Thomas G. (1992) Inhibition or down-regulation of protein kinase C attenuates late phase p70s6k activation induced by epidermal growth factor but not by platelet-derived growth factor or insulin. J. Biol. Chem. 267, 6905-6909.
50. 3 receptor-stimulated polyphosphoinositide responses. Mol. Pharmacol. 42, 1042-1048.
51. Traverse S., Gomez N., Paterson H., Marshall C., and Cohen P. (1992) Sustained activation of the mitogen-actwated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288, 351-355.
52. van Biesen T., Hawes B. E., Raymond J. R., Luttrell L. M., Koch W. J., and Lefkowitz R. J. (1997) Go-protein α-subunits activate mitogen-activated protein kinase via a novelprotein kinase C-dependent mechanism. J. Biol. Chem. 271, 1266-1269.
53. van Biesen T., Hawes B. E., Luttrell D. K., Krueger K. M., Touhara K., Porfiri E., Sakaue M., Luttrell L. M., and Lefkowitz R. J. (1995) Receptor-tyrosine-kinase-mediated and G (β-γ)-mediated MAP kinase activation by a common signalling pathway. Nature 376, 781-784.
54. Wan Y., Kurosaki T., and Huang X. (1996) Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature 380, 541-544.
55. Welsh G. I., Foulstone E. J., Young S. W., Tavaré J. M., and Proud C. G. (1994) Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. Biochem. J. 303, 15-20.
56. Weng Q.-P., Andrabi K., Kozlowski M. T., Grove J. R., and Avruch J. (1995a) Multiple independent inputs are required for activation of the p70 S6 kinase. Mol. Cell. Biol. 15, 2333-2340.
57. Weng Q. P., Andrabi, K., Klippel A., Kozlowski M. T. Williams L. T., and Avruch J. (1995b) Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proc. Natl. Acad. Sci. USA 92, 5744-5748.
58. i-coupled receptors. J. Biol. Chem. 271, 8537-8540.
59. Young S. W., Dickens M., and Tavare J. M. (1994) Differentiation of PC12 cells in response to a cAMP analogue is accompanied by a sustained activation of mitogen-activated protein kinase. Comparison with the effects of insulin, growth factors and phorbol esters. FEBS Lett. 338, 212-216.